Aura Biosciences

(NASDAQ) AURA

Current Price$6.98

Market Cap$709.23M

Since IPO (2021)-53%

5 YearN/A

1 Year+11%

1 Month-9%

Aura Biosciences Financials at a Glance

Market Cap

$709.23M

Revenue (TTM)

$0.00

Net Income (TTM)

-$112.39M

EPS (TTM)

-$1.76

P/E Ratio

-3.89

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$6.98

Volume

45,617

Open

$6.97

Price

$6.98

Volume

45,617

Open

$6.97

Previous Close

$6.98

Daily Range

$6.83 - $7.11

52-Week Range

$4.73 - $9.54

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$6.98

Volume

45,617

Open

$6.97

Previous Close

$6.98

Daily Range

$6.83 - $7.11

52-Week Range

$4.73 - $9.54

Estimated Earnings Date

Aug 12, 2026

AURA News

Aura Biosciences Posts Q2 Cash Surge

Motley Fool Markets TeamAug 13, 2025

Why Shares of Aura Biosciences Jumped This Week

James HalleyFeb 10, 2023

AURA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aura Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

113

CEO

Elisabet de los Pinos, PhD, MBA

Website

www.aurabiosciences.com

Headquarters

Boston, MA 02140, US

AURA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-78.12%

Return on Capital

-73.10%

Return on Assets

-81.64%

Earnings Yield

-25.71%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$709.23M

Shares Outstanding

103.39M

Volume

45.62K

Avg. Volume

552.63K

Financials (TTM)

Gross Profit

-$574.00K

Operating Income

-$118.62M

EBITDA

-$111.17M

Operating Cash Flow

-$91.28M

Capital Expenditure

-$362.00K

Free Cash Flow

-$91.64M

Cash & ST Invst.

$114.73M

Total Debt

$16.99M

Aura Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$274.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$709.23M

N/A

Market Cap/Employee

$6.69M

N/A

Employees

106

N/A

Net Income

-$33.69M

-22.6%

EBITDA

-$33.40M

-22.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$114.73M

-10.4%

Total Debt

$16.99M

-7.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$13.72M

-10.1%

Short Term Debt

$3.27M

+3.0%

Return on Assets

-81.64%

N/A

Return on Invested Capital

-98.06%

N/A

Free Cash Flow

-$30.00M

-27.4%

Operating Cash Flow

-$29.89M

-28.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLDBSolid Biosciences Inc.

SLDBSolid Biosciences Inc.$9.29+4.85%

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$5.48+6.41%

DSGNDesign Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.$13.35-0.67%

LBRXLB Pharmaceuticals Inc Common Stock

LBRXLB Pharmaceuticals Inc Common Stock$31.92+2.97%

DBVTDBV Technologies S.A.

DBVTDBV Technologies S.A.$16.01-0.06%

RCKTRocket Pharmaceuticals, Inc.

RCKTRocket Pharmaceuticals, Inc.$3.25+0.31%

ALTAltimmune, Inc.

ALTAltimmune, Inc.$2.82-1.74%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$192.53-0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

Questions About AURA

What is the current price of Aura Biosciences?

Aura Biosciences is trading at $6.98 per share.

What is the 52-week range for Aura Biosciences?

Over the past 52 weeks, Aura Biosciences has traded between $4.73 and $9.54.

How much debt does Aura Biosciences have?

As of the most recent reporting period, Aura Biosciences reported total debt of $16.99M.

How much cash does Aura Biosciences have on hand?

Aura Biosciences reported $84.79M in cash and cash equivalents in its most recent financial results.

What is Aura Biosciences’s dividend yield?

Aura Biosciences does not currently have a dividend yield.

Aura Biosciences

Aura Biosciences Financials at a Glance

AURA News

Aura Biosciences Posts Q2 Cash Surge

Why Shares of Aura Biosciences Jumped This Week

AURA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aura Biosciences

AURA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aura Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AURA

What is the current price of Aura Biosciences?

What is the 52-week range for Aura Biosciences?

How much debt does Aura Biosciences have?

How much cash does Aura Biosciences have on hand?

What is Aura Biosciences’s dividend yield?

Premium Investing Services